+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical, Stability Testing, Method Development & Validation), And Segment Forecasts, 2019 - 2026

  • ID: 4764564
  • Report
  • 100 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Boston Analytical
  • Eurofins Scientific
  • Exova Group plc.
  • Intertek Group plc
  • SGS SA
  • Toxikon, Inc.
  • MORE
The global pharmaceutical analytical testing outsourcing market size is projected to reach USD 10.4 billion by 2026 expanding at a CAGR of 8.1%. Focus on the analytical testing of biopharmaceuticals and biosimilars, adoption of Full Time Equivalent Agreements (FTE), and increased outsourcing of analytical testing services to contract pharma companies are propelling the market growth. Demand for biosimilars and pharmaceutical drugs is expected to increase substantially over the forecast period. Thus, to fulfil the rising demand, key pharmaceutical companies and government bodies are working collaboratively.

For instance, in August 2018, the Swedish government collaborated with GE Healthcare to establish a new innovation center for testing of new discoveries in the pharmaceutical sector. Major companies may lack the required manufacturing set-up and expertise to carry out in-house testing services. This leads to the outsourcing of in-house work to contract pharmaceutical companies. In addition, several ancillary works, such as registration, storage and testing, process and facility validation, and cleaning validations, are outsourced to remain competitive in the market. These factors will boost the market growth in the years to come.

Further key findings from the study suggest:
  • Clinical bioanalytical testing services is projected to be the largest service segment over the forecast period
  • Increasing number of clinical trial registrations and entry of new contract pharma companies are the factors responsible for the segment growth
  • North America led the global pharmaceutical analytical testing outsourcing market in 2018 due to government support and strong presence of key pharmaceutical outsourcing companies
  • Some of the key companies in the market are SGS SA; Intertek Group PLC; Pharmaceutical Product Development, LLC; Toxikon, Inc.; Exova Group PLC, Eurofins Scientific; Pace Analytical Services, LLC; Charles River Laboratories International, Inc.; Boston Analytical, Inc.; and West Pharmaceutical Services, Inc.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Boston Analytical
  • Eurofins Scientific
  • Exova Group plc.
  • Intertek Group plc
  • SGS SA
  • Toxikon, Inc.
  • MORE
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information procurement
1.2.1 Purchased database
1.2.2 Internal database
1.2.3 Secondary sources & third party perspectives
1.2.4 Primary research
1.3 Information analysis
1.3.1 Data analysis models
1.4 Market formulation & data visualization
1.5 Data validation & publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 User perspective analysis
3.4.1 Consumer Behavior Analysis
3.4.2 Market Influencer Analysis
3.5 List of Key End-users, by region / by product / by country
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards & Compliances
3.7 Market Dynamics
3.7.1 Market Driver Analysis
3.7.1.1 Innovation
3.7.1.2 Regulatory safety and quality
3.7.1.3 End users volume
3.7.2 Market Restraint Analysis
3.7.2.1 Data security
3.7.2.2 Third party performance
3.7.3 Industry Challenges
3.7.3.1 Implementation issues
3.8 Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
3.8.1 Industry Analysis – Porter’s
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Substitution Threat
3.8.1.4 Threat from new entrant
3.8.1.5 Competitive rivalry
3.8.2 PESTEL Analysis
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social Landscape
3.8.2.4 Technology Landscape
3.8.2.5 Legal Landscape
3.8.3 Major Deals & Strategic Alliances Analysis
3.8.3.1 Joint Ventures
3.8.3.2 Mergers & Acquisitions
3.8.3.3 Licensing & Partnership
3.8.3.4 Technology Collaborations
3.8.3.5 Strategic Divestments
3.8.4 Market Entry Strategies

Chapter 4 Pharmaceutical Analytical Testing Outsourcing Market: Segment Analysis, By Service, 2015 - 2026 (USD Million)
4.1 Definitions & Scope
4.2 Services market share analysis, 2018 & 2026
4.3 Segment Dashboard
4.4 Global Pharmaceutical Analytical Testing Outsourcing Market, by Service, 2015 to 2026
4.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1 Bioanalytical Testing
4.5.1.1 Clinical
4.5.1.2 Non-clinical
4.5.2 Method Development & Validation
4.5.2.1 Other regulatory services
4.5.2.2 ExtracTable & Leachable
4.5.2.3 Impurity Method
4.5.2.4 Technical Consulting
4.5.2.5 Others
4.5.3 Stability Testing
4.5.3.1 Drug Substance
4.5.3.2 Stability Indicating Method Validation
4.5.3.3 Accelerated Stability Testing
4.5.3.4 Photo-stability Testing
4.5.3.5 Others
4.5.4 Others

Chapter 5 Pharmaceutical Analytical Testing Outsourcing Market: Regional Market Analysis, 2015 - 2026 (USD Million)
5.1 Definitions & Scope
5.2 Regional market share analysis, 2018 & 2026
5.3 Regional Market Dashboard
5.4 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.5 Regional Market Share and Leading Players, 2018
5.5.1 North America
5.5.2 Europe
5.5.3 Asia Pacific
5.5.4 Latin America
5.5.5 Middle East & Africa
5.6 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
5.6.1 North America
5.6.2 Europe
5.6.3 Asia Pacific
5.6.4 Latin America
5.6.5 Middle East & Africa
5.7 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2026:
5.8 North America
5.8.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.8.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.8.3 U.S.
5.8.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.8.4 Canada
5.8.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.9 Europe
5.9.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.9.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.9.3 Germany
5.9.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.9.4 U.K.
5.9.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.9.5 France
5.9.5.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.9.6 Italy
5.9.6.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.9.7 Spain
5.9.7.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.10 Asia Pacific
5.10.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.10.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.10.3 China
5.10.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.10.4 Japan
5.10.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.10.5 India
5.10.5.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.10.6 Thailand
5.10.6.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.10.7 South Korea
5.10.7.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.11 Latin America
5.11.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.11.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.11.3 Brazil
5.11.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.11.4 Mexico
5.11.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.11.5 Argentina
5.11.5.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.11.6 Colombia
5.11.6.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.12 Middle East & Africa
5.12.1 Market estimates and forecast, by country, 2015 - 2026 (USD Million)
5.12.2 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.12.3 South Africa
5.12.3.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.12.4 Saudi Arabia
5.12.4.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)
5.12.5 UAE
5.12.5.1 Market estimates and forecast, by service, 2015 - 2026 (USD Million)

Chapter 6 Pharmaceutical Analytical Testing Outsourcing Market – Competitive Analysis
6.1 Recent developments & impact analysis, by key market participants
6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3 Vendor Landscape
6.3.1 List of key distributors and channel partners
6.3.2 Key customers
6.3.3 Key company market share analysis, 2018
6.4 Public Companies
6.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.4.2 Company Market Share/Ranking, by region
6.4.3 Competitive Dashboard Analysis
6.4.3.1 Market Differentiators
6.4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
6.5 Private Companies
6.5.1 List of key emerging companies’ /technology disruptors/innovators
6.5.2 Funding Outlook (Optional)
6.5.3 Regional network map
6.5.4 Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
6.6 Supplier Ranking
6.7 Key companies profiled
6.7.1 SGS SA
6.7.1.1 Company Overview
6.7.1.2 Financial Performance
6.7.1.3 Product Benchmarking
6.7.1.4 Strategic Initiatives
6.7.2 Toxikon, Inc.
6.7.2.1 Company Overview
6.7.2.2 Financial Performance
6.7.2.3 Product Benchmarking
6.7.2.4 Strategic Initiatives
6.7.3 Eurofins Scientific
6.7.3.1 Company Overview
6.7.3.2 Financial Performance
6.7.3.3 Product Benchmarking
6.7.3.4 Strategic Initiatives
6.7.4 Pace Analytical Services LLC.
6.7.4.1 Company Overview
6.7.4.2 Financial Performance
6.7.4.3 Product Benchmarking
6.7.4.4 Strategic Initiatives
6.7.5 Intertek Group plc
6.7.5.1 Company Overview
6.7.5.2 Financial Performance
6.7.5.3 Product Benchmarking
6.7.5.4 Strategic Initiatives
6.7.6 Pharmaceutical Product Development, LLC.
6.7.6.1 Company Overview
6.7.6.2 Financial Performance
6.7.6.3 Product Benchmarking
6.7.6.4 Strategic Initiatives
6.7.7 Exova Group plc.
6.7.7.1 Company Overview
6.7.7.2 Financial Performance
6.7.7.3 Product Benchmarking
6.7.7.4 Strategic Initiatives
6.7.8 Boston Analytical
6.7.8.1 Company Overview
6.7.8.2 Financial Performance
6.7.8.3 Product Benchmarking
6.7.8.4 Strategic Initiatives
6.7.9 Charles River Laboratories International, Inc.
6.7.9.1 Company Overview
6.7.9.2 Financial Performance
6.7.9.3 Product Benchmarking
6.7.9.4 Strategic Initiatives
6.7.10 West Pharmaceutical Services
6.7.10.1 Company Overview
6.7.10.2 Financial Performance
6.7.10.3 Product Benchmarking
6.7.10.4 Strategic Initiatives

Chapter 7 KOL Commentary

Chapter 8 Recommendations

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • SGS SA
  • Toxikon, Inc.
  • Eurofins Scientific
  • Pace Analytical Services LLC.
  • Intertek Group plc
  • Pharmaceutical Product Development, LLC.
  • Exova Group plc.
  • Boston Analytical
  • Charles River Laboratories International, Inc.
  • West Pharmaceutical Services
Note: Product cover images may vary from those shown
Adroll
adroll